National trends in the use of surgery for benign hepatic tumors in the United States
- PMID: 25769697
- PMCID: PMC4696004
- DOI: 10.1016/j.surg.2015.01.015
National trends in the use of surgery for benign hepatic tumors in the United States
Abstract
Background: The widespread use of diagnostic imaging has led to an increase in the incidence and diagnosis of benign liver tumors. The objective of this study was to define the overall use and temporal trends of operative procedures for benign liver tumors using a nationally representative cohort.
Methods: All patients who underwent liver surgery for benign liver tumors between 2000 and 2011 were identified from the Nationwide Inpatient Sample database. Trends in annual volume of liver procedures were analyzed using the average annual percent change (AAPC) assessed by joinpoint analysis.
Results: There were 2,489 open (94.5%) and 144 (5.5%) minimally invasive surgical (MIS) procedures. Partial hepatectomy accounted for 43.8% of all cases (n = 1,153). Surgery for patients with benign liver tumors increased from 156 in 2000 to 272 in 2011 (AAPC, 5.8%; 95% CI, 3.2-8.6%). There was decline in the relative use of open operative procedures from 98.1% in 2000 to 92.3% in 2011 (AAPC, -0.4%; 95% CI, -0.7 to -0.1%). In contrast, the proportion of MIS procedures increased from 1.9% in 2000 to 7.7% in 2011 (AAPC, 7.4%; 95% CI, 1.9-13.3%). The median duration of stay among all patients was 5 days (interquartile range, 4-7; 5 days [open] vs 3 days [MIS]; P < .001). Inpatient mortality was 0.6% (n = 15 [open] vs n = 0 [MIS]; P = .43) and did not change during the study period (P > .05).
Conclusion: Overall volume of surgical management of benign liver tumors has increased substantially over the past decade. There has been a relative shift away from open procedures toward MIS procedures.
Copyright © 2015 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest: none.
Figures
Similar articles
-
National Trends in Postoperative Outcomes and Cost Comparing Minimally Invasive Versus Open Liver and Pancreatic Surgery.J Gastrointest Surg. 2016 Nov;20(11):1836-1843. doi: 10.1007/s11605-016-3267-z. Epub 2016 Sep 9. J Gastrointest Surg. 2016. PMID: 27613735
-
National trends in surgical procedures for hepatocellular carcinoma: 1998-2008.Cancer. 2012 Apr 1;118(7):1838-44. doi: 10.1002/cncr.26501. Epub 2011 Aug 25. Cancer. 2012. PMID: 22009384
-
The trend towards minimally invasive surgery (MIS) for endometrial cancer: an ACS-NSQIP evaluation of surgical outcomes.Gynecol Oncol. 2015 Mar;136(3):512-5. doi: 10.1016/j.ygyno.2014.11.014. Epub 2014 Nov 20. Gynecol Oncol. 2015. PMID: 25462206
-
Current status of hepatic resection.Adv Surg. 2003;37:29-49. Adv Surg. 2003. PMID: 12953626 Review.
-
MIS-behavior: practical heuristics for precise pediatric minimally invasive surgery.Urol Clin North Am. 2015 Feb;42(1):131-40. doi: 10.1016/j.ucl.2014.09.011. Epub 2014 Oct 11. Urol Clin North Am. 2015. PMID: 25455179 Review.
Cited by
-
Effect of minimally invasive versus open surgery in hepatectomy on postoperative wound complications in patients with hepatocellular carcinoma: A meta-analysis.Int Wound J. 2023 Dec;20(10):4159-4165. doi: 10.1111/iwj.14313. Epub 2023 Jul 13. Int Wound J. 2023. PMID: 37442783 Free PMC article.
-
Hepatocellular Carcinoma Arising from Hepatocellular Adenoma in an Elderly Male Patient.J Liver Cancer. 2021 Mar;21(1):87-91. doi: 10.17998/jlc.21.1.87. Epub 2021 Mar 31. J Liver Cancer. 2021. PMID: 37384277 Free PMC article.
-
Serum thymidine kinase 1 protein concentration for predicting early progression and monitoring the response to TACE in hepatocellular carcinomas: a network meta-analysis.Future Sci OA. 2021 May 21;7(7):FSO717. doi: 10.2144/fsoa-2021-0016. eCollection 2021 Aug. Future Sci OA. 2021. PMID: 34258026 Free PMC article.
-
Minimally invasive versus open right hepatectomy: comparative study with propensity score matching analysis.BMC Surg. 2020 Oct 30;20(1):260. doi: 10.1186/s12893-020-00919-0. BMC Surg. 2020. PMID: 33126885 Free PMC article.
-
Current concepts in ablative procedures for primary benign liver lesions: a step forward to minimize the invasiveness of treatment when deemed necessary.Med Oncol. 2020 Mar 19;37(4):31. doi: 10.1007/s12032-020-01355-z. Med Oncol. 2020. PMID: 32193648 Free PMC article. Review.
References
-
- Mortele KJ, Ros PR. Benign liver neoplasms. Clin Liver Dis. 2002;6:119–45. - PubMed
-
- Cristiano A, Dietrich A, Spina JC, Ardiles V, de Santibanes E. Focal nodular hyperplasia and hepatic adenoma: current diagnosis and management. Updates Surg. 2014;66:9–21. - PubMed
-
- Ishak KG, Rabin L. Benign tumors of the liver. Med Clin North Am. 1975;59:995–1013. - PubMed
-
- Vachha B, Sun MR, Siewert B, Eisenberg RL. Cystic lesions of the liver. Am J Roentgenol. 2011;196:W355–66. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
